| Improved outcomes in nephrotic syndrome. | |
| | |
MedLine Citation:
|
PMID: 16478040 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Nephrotic syndrome can now be treated effectively in most cases. All patients should be treated with a low-salt diet, diuretics to reduce edema, and statins to normalize serum lipid concentrations. Patients with nephrotic syndrome are prone to deep vein thrombophlebitis, renal vein thrombosis, and pulmonary emboli. Depending on the condition, additional treatment may include corticosteroids, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), cyclosporine, cytotoxic agents, or mycophenolate. |
| | |
Authors:
|
Gerald B Appel |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Cleveland Clinic journal of medicine Volume: 73 ISSN: 0891-1150 ISO Abbreviation: Cleve Clin J Med Publication Date: 2006 Feb |
Date Detail:
|
Created Date: 2006-02-15 Completed Date: 2006-03-16 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8703441 Medline TA: Cleve Clin J Med Country: United States |
Other Details:
|
Languages: eng Pagination: 161-7 Citation Subset: IM |
Affiliation:
|
Columbia University College of Physicians and Surgeons, New York, NY, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiotensin-Converting Enzyme Inhibitors
/
therapeutic use Cyclosporine / therapeutic use Diagnosis, Differential Diet, Sodium-Restricted Diuretics / therapeutic use Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use Immunosuppressive Agents / therapeutic use Mycophenolic Acid / analogs & derivatives, therapeutic use Nephrotic Syndrome / diagnosis*, diet therapy, drug therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors; 0/Diuretics; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Immunosuppressive Agents; 128794-94-5/mycophenolate mofetil; 24280-93-1/Mycophenolic Acid; 59865-13-3/Cyclosporine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Natriuretic peptide testing: a window into the diagnosis and prognosis of heart failure.
Next Document: Clostridium difficile-associated disease: new challenges from an established pathogen.